{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:34:32Z","timestamp":1791934472366,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T00:00:00Z","timestamp":1455148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T00:00:00Z","timestamp":1455148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Circulating memory T follicular helper subsets, Tfh2 and Tfh17 are found to be aberrantly regulated in many autoimmune diseases. However, their roles in the pathogenesis of GBS are still unclear. This study examined the phenotype, distribution, clinical relevance and potential function of Tfh2 and Tfh17 in 36 GBS patients (including 24 AMAN and 12 AIDP patients). We found that the absolute counts of total memory Tfh cells were significantly increased in AMAN, while no significant difference in AIDP compared with HC. Furthermore, the levels of the three subsets of memory Tfh cells, Tfh1, Tfh2 and Tfh17, were differentially altered in AMAN. The absolute counts of Tfh1, Tfh2 and Tfh17 were all increased to a higher level in AMAN. The ratio of (Tfh2+Tfh17)\/Tfh1 and the percentages of ICOS<jats:sup>+<\/jats:sup> cells in Tfh2 and Tfh17 cells were greater in AMAN when compared to AIDP and HC and the former had a positive correlation with the severity of both AMAN and AIDP. Conversely, the percentages of PD1<jats:sup>+<\/jats:sup> cells in Tfh2 and Tfh17 cells were lower in AMAN than in HC. Therefore, circulating memory Tfh2 and Tfh17 cells might promote the autoantibody-related immune response and serve as useful markers to evaluate the progression of AMAN.<\/jats:p>","DOI":"10.1038\/srep20963","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T11:53:43Z","timestamp":1455191623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Circulating memory T follicular helper subsets, Tfh2 and Tfh17, participate in the pathogenesis of Guillain-Barr\u00e9 syndrome"],"prefix":"10.1038","volume":"6","author":[{"given":"Yuanyuan","family":"Che","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,11]]},"reference":[{"key":"BFsrep20963_CR1","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/S0140-6736(04)16512-4","volume":"363","author":"J Pritchard","year":"2004","unstructured":"Pritchard, J. & Hughes, R. A. Guillain-Barre syndrome. Lancet. 363, 2186\u20132188 (2004).","journal-title":"Lancet."},{"key":"BFsrep20963_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","volume":"100","author":"RA Hughes","year":"1999","unstructured":"Hughes, R. A., Hadden, R. D., Gregson, N. A. & Smith, K. J. Pathogenesis of Guillain-Barre syndrome. J. Neuroimmunol. 100, 74\u201397 (1999).","journal-title":"J. Neuroimmunol."},{"key":"BFsrep20963_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","volume":"24","author":"HL Zhang","year":"2013","unstructured":"Zhang, H. L., Zheng, X. Y. & Zhu, J. Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev. 24, 443\u2013453 (2013).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFsrep20963_CR4","first-page":"260473","volume":"2012","author":"S Li","year":"2012","unstructured":"Li, S. et al. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barre syndrome. Mediators Inflamm. 2012, 260473 (2012).","journal-title":"Mediators Inflamm."},{"key":"BFsrep20963_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","volume":"84","author":"J Zhu","year":"1998","unstructured":"Zhu, J., Mix, E. & Link, H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barre syndrome. J. Neuroimmunol. 84, 40\u201352 (1998).","journal-title":"J. Neuroimmunol."},{"key":"BFsrep20963_CR6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","volume":"15","author":"J Harness","year":"2008","unstructured":"Harness, J. & McCombe, P. A. Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain-Barre syndrome patients compared to controls. J. Clin Neurosci. 15, 1031\u20131035 (2008).","journal-title":"J. Clin Neurosci."},{"key":"BFsrep20963_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.it.2011.02.007","volume":"32","author":"J Zepp","year":"2011","unstructured":"Zepp, J., Wu, L. & Li, X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 32, 232\u2013239 (2011).","journal-title":"Trends Immunol."},{"key":"BFsrep20963_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/sji.12201","volume":"80","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis. Scand J Immunol. 80, 180\u2013190 (2014).","journal-title":"Scand J Immunol."},{"key":"BFsrep20963_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2183\/pjab.88.299","volume":"88","author":"N Yuki","year":"2012","unstructured":"Yuki, N. Guillain-Barre syndrome and anti-ganglioside antibodies: a clinician-scientist\u2019s journey. Proc Jpn Acad Ser B Phys Biol Sci. 88, 299\u2013326 (2012).","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci."},{"key":"BFsrep20963_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/JCI59110","volume":"122","author":"SN Fewou","year":"2012","unstructured":"Fewou, S. N. et al. Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy. J. Clin Invest. 122, 1037\u20131051 (2012).","journal-title":"J. Clin Invest."},{"key":"BFsrep20963_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"C Hafer-Macko","year":"1996","unstructured":"Hafer-Macko, C. et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol. 40, 635\u2013644 (1996).","journal-title":"Ann Neurol."},{"key":"BFsrep20963_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/cei.12215","volume":"175","author":"PM Abraham","year":"2014","unstructured":"Abraham, P. M., Quan, S. H., Dukala, D. & Soliven, B. CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy. Clin Exp Immunol. 175, 181\u2013191 (2014).","journal-title":"Clin Exp Immunol."},{"key":"BFsrep20963_CR13","first-page":"1329","volume":"67","author":"Y Nakano","year":"2015","unstructured":"Nakano, Y. & Kanda, T. Pathology of the Peripheral Nervous System in Guillain-Barr\u00e9 Syndrome. Brain Nerve. 67, 1329\u201339 (2015).","journal-title":"Brain Nerve."},{"key":"BFsrep20963_CR14","doi-asserted-by":"publisher","first-page":"e104074","DOI":"10.1371\/journal.pone.0104074","volume":"9","author":"X Wu","year":"2014","unstructured":"Wu, X. et al. More severe manifestations and poorer short-term prognosis of ganglioside-associated Guillain-Barre syndrome in Northeast China. PLoS One. 9, e104074 (2014).","journal-title":"PLoS One."},{"key":"BFsrep20963_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty, S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 29, 621\u2013663 (2011).","journal-title":"Annu Rev Immunol."},{"key":"BFsrep20963_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2011","unstructured":"Morita, R. et al. Human blood CXCR5(+) CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 34, 108\u2013121 (2011).","journal-title":"Immunity."},{"key":"BFsrep20963_CR17","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1007\/s00018-013-1420-3","volume":"70","author":"J Tellier","year":"2013","unstructured":"Tellier, J. & Nutt, S. L. The unique features of follicular T cell subsets. Cell Mol Life Sci. 70, 4771\u20134784 (2013).","journal-title":"Cell Mol Life Sci."},{"key":"BFsrep20963_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bbrc.2012.04.133","volume":"422","author":"XY Li","year":"2012","unstructured":"Li, X. Y. et al. Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjogren\u2019s syndrome. Biochem Biophys Res Commun. 422, 238\u2013244 (2012).","journal-title":"Biochem Biophys Res Commun."},{"key":"BFsrep20963_CR19","doi-asserted-by":"publisher","first-page":"e57820","DOI":"10.1371\/journal.pone.0057820","volume":"8","author":"J Romme Christensen","year":"2013","unstructured":"Romme Christensen, J. et al. Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression. PLoS One. 8, e57820 (2013).","journal-title":"PLoS One."},{"key":"BFsrep20963_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.12.001","volume":"256","author":"C Luo","year":"2013","unstructured":"Luo, C. et al. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis. J. Neuroimmunol. 256, 55\u201361 (2013).","journal-title":"J. Neuroimmunol."},{"key":"BFsrep20963_CR21","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.clinph.2012.01.025","volume":"123","author":"A Uncini","year":"2012","unstructured":"Uncini, A. & Kuwabara, S. Electrodiagnostic criteria for Guillain-Barre syndrome: a critical revision and the need for an update. Clin Neurophysiol. 123, 1487\u20131495 (2012).","journal-title":"Clin Neurophysiol."},{"key":"BFsrep20963_CR22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes, R. A., Newsom-Davis, J. M., Perkin, G. D. & Pierce, J. M. Controlled trial prednisolone in acute polyneuropathy. Lancet. 2, 750\u2013753 (1978).","journal-title":"Lancet."},{"key":"BFsrep20963_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/mus.880141111","volume":"14","author":"RP Kleyweg","year":"1991","unstructured":"Kleyweg, R. P., van der Meche, F. G. & Schmitz, P. I. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve. 14, 1103\u20131109 (1991).","journal-title":"Muscle Nerve."},{"key":"BFsrep20963_CR24","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","volume":"179","author":"VL Bryant","year":"2007","unstructured":"Bryant, V. L. et al. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179, 8180\u20138190 (2007).","journal-title":"J. Immunol."},{"key":"BFsrep20963_CR25","doi-asserted-by":"publisher","first-page":"e75319","DOI":"10.1371\/journal.pone.0075319","volume":"8","author":"C Le Coz","year":"2013","unstructured":"Le Coz, C. et al. Circulating TFH subset distribution is strongly affected in lupus patients with an active disease. PLoS One. 8, e75319 (2013).","journal-title":"PLoS One."},{"key":"BFsrep20963_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4110\/in.2014.14.1.21","volume":"14","author":"HJ Park","year":"2014","unstructured":"Park, H. J. et al. Insights into the role of follicular helper T cells in autoimmunity. Immune Netw. 14, 21\u201329 (2014).","journal-title":"Immune Netw."},{"key":"BFsrep20963_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.coi.2011.12.009","volume":"24","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L., Drake, C. G. & Pardoll, D. M. Targeting the PD-1\/B7-H1(PD-L1) pathway to activate anti-tumor immunity. Curr Opin Immunol. 24, 207\u2013212 (2012).","journal-title":"Curr Opin Immunol."},{"key":"BFsrep20963_CR28","first-page":"131","volume":"13","author":"X Zhang","year":"2013","unstructured":"Zhang, X. et al. Follicular helper T cells: new insights into mechanisms of autoimmune diseases. Ochsner J. 13, 131\u2013139 (2013).","journal-title":"Ochsner J."},{"key":"BFsrep20963_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.20081886","volume":"206","author":"MA Linterman","year":"2009","unstructured":"Linterman, M. A. et al. Follicular helper T cells are required for systemic autoimmunity. J. Exp Med. 206, 561\u2013576 (2009).","journal-title":"J. Exp Med."},{"key":"BFsrep20963_CR30","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/rheumatology\/ket434","volume":"53","author":"G Papp","year":"2014","unstructured":"Papp, G., Szabo, K., Szekanecz, Z. & Zeher, M. Follicular helper T cells in autoimmune diseases. Rheumatology (Oxford). 53, 1159\u20131160 (2014).","journal-title":"Rheumatology (Oxford)."},{"key":"BFsrep20963_CR31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/art.25032","volume":"62","author":"N Simpson","year":"2010","unstructured":"Simpson, N. et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 62, 234\u2013244 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFsrep20963_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1212\/01.wnl.0000250240.99311.9d","volume":"68","author":"W Hu","year":"2007","unstructured":"Hu, W. et al. Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies. Neurology. 68, 277\u2013282 (2007).","journal-title":"Neurology."},{"key":"BFsrep20963_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","volume":"236","author":"LM Francisco","year":"2010","unstructured":"Francisco, L. M., Sage, P. T. & Sharpe, A. H. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev. 236, 219\u2013242 (2010).","journal-title":"Immunol Rev."},{"key":"BFsrep20963_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cellimm.2014.05.006","volume":"290","author":"S Dai","year":"2014","unstructured":"Dai, S. et al. The PD-1\/PD-Ls pathway and autoimmune diseases. Cell Immunol. 290, 72\u201379 (2014).","journal-title":"Cell Immunol."},{"key":"BFsrep20963_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jneuroim.2006.10.006","volume":"182","author":"LL Carter","year":"2007","unstructured":"Carter, L. L. et al. PD-1\/PD-L1, but not PD-1\/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 182, 124\u2013134 (2007).","journal-title":"J. Neuroimmunol."},{"key":"BFsrep20963_CR36","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1212\/WNL.38.10.1639","volume":"38","author":"RP Kleyweg","year":"1988","unstructured":"Kleyweg, R. P., van der Meche, F. G. & Meulstee, J. Treatment of Guillain-Barre syndrome with high-dose gammaglobulin. Neurology. 38, 1639\u20131641 (1988).","journal-title":"Neurology."},{"key":"BFsrep20963_CR37","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1093\/brain\/awg235","volume":"126","author":"BC Jacobs","year":"2003","unstructured":"Jacobs, B. C. et al. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain. 126, 2220\u20132234 (2003).","journal-title":"Brain."},{"key":"BFsrep20963_CR38","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/brain\/awh127","volume":"127","author":"G Zhang","year":"2004","unstructured":"Zhang, G. et al. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies. Brain. 127, 1085\u20131100 (2004).","journal-title":"Brain."},{"key":"BFsrep20963_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12883-014-0202-3","volume":"14","author":"HQ Hou","year":"2014","unstructured":"Hou, H. Q. et al. Changes in lymphocyte subsets in patients with Guillain-Barre syndrome treated with immunoglobulin. BMC Neurol. 14, 202 (2014).","journal-title":"BMC Neurol."},{"key":"BFsrep20963_CR40","first-page":"740947","volume":"2014","author":"S Li","year":"2014","unstructured":"Li, S. et al. Circulating Th17, Th22 and Th1 cells are elevated in the Guillain-Barre syndrome and downregulated by IVIg treatments. Mediators Inflamm. 2014, 740947 (2014).","journal-title":"Mediators Inflamm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep20963","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20963.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20963.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T13:26:00Z","timestamp":1672838760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep20963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,8,26]]}},"alternative-id":["BFsrep20963"],"URL":"https:\/\/doi.org\/10.1038\/srep20963","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,11]]},"assertion":[{"value":"23 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20963"}}